Product Recalls in New Jersey

Product recalls affecting New Jersey — including food, drugs, consumer products, medical devices, and vehicles distributed to New Jersey. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,820 recalls have been distributed to New Jersey in the last 12 months.

53,621 total recalls
2,820 in last 12 months

Showing 80018020 of 13,536 recalls

DrugApril 21, 2017· Hospira Inc.

Recalled Item: Infant 25% DEXTROSE Injection Recalled by Hospira Inc. Due to Presence of...

The Issue: Presence of Particulate Matter: human hair found within an internal sample...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 20, 2017· C. O. Truxton

Recalled Item: Phenobarbital Tablets USP Recalled by C. O. Truxton Due to Mislabeling

The Issue: Labeling: Label Mixup; potentially mislabeled

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 20, 2017· Akorn, Inc.

Recalled Item: IC-Green (indocyanine green for injection Recalled by Akorn, Inc. Due to...

The Issue: Product is being recalled due to low pH value.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 20, 2017· C. O. Truxton

Recalled Item: Amitriptyline HCL Tablets Recalled by C. O. Truxton Due to Mislabeling

The Issue: Labeling: Label Mixup; potentially mislabeled

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 20, 2017· C. O. Truxton

Recalled Item: Phenobarbital Tablets USP Recalled by C. O. Truxton Due to Mislabeling

The Issue: Labeling: Label Mixup; potentially mislabeled

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 20, 2017· C. O. Truxton

Recalled Item: Phenobarbital Tablets USP Recalled by C. O. Truxton Due to Labeling: Labeled...

The Issue: Labeling: Labeled Error on Declared Strength; report of a 1000 ct bottle...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 20, 2017· C. O. Truxton

Recalled Item: Phenobarbital Tablets USP Recalled by C. O. Truxton Due to Mislabeling

The Issue: Labeling: Label Mixup; potentially mislabeled

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 20, 2017· C. O. Truxton

Recalled Item: Phenobarbital Tablets USP Recalled by C. O. Truxton Due to Mislabeling

The Issue: Labeling: Label Mixup; potentially mislabeled

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 19, 2017· Qualgen

Recalled Item: Estradiol 6 mg pellet 99.5% Estradiol USP Recalled by Qualgen Due to CGMP...

The Issue: CGMP deviations- Lack of Quality Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 19, 2017· Qualgen

Recalled Item: Estradiol 12.5 mg pellet 99.5% Estradiol USP Recalled by Qualgen Due to CGMP...

The Issue: CGMP deviations- Lack of Quality Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 19, 2017· Qualgen

Recalled Item: Estradiol 20 mg pellet 99.5% Estradiol USP Recalled by Qualgen Due to CGMP...

The Issue: CGMP deviations- Lack of Quality Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 19, 2017· Qualgen

Recalled Item: Estradiol 22 mg pellet 99.5% Estradiol USP Recalled by Qualgen Due to CGMP...

The Issue: CGMP deviations- Lack of Quality Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 19, 2017· Qualgen

Recalled Item: Estradiol 18 mg pellet Recalled by Qualgen Due to CGMP deviations- Lack of...

The Issue: CGMP deviations- Lack of Quality Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 19, 2017· Qualgen

Recalled Item: Estradiol 25 mg pellet 99.5% Estradiol USP Recalled by Qualgen Due to CGMP...

The Issue: CGMP deviations- Lack of Quality Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 19, 2017· Gentell, Inc

Recalled Item: Shield and Protect Moisture Barrier Cream Recalled by Gentell, Inc Due to...

The Issue: GMP Deviations; product may not meet cGMP requirements

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 19, 2017· Qualgen

Recalled Item: Estradiol 10 mg pellet 99.5% Estradiol USP Recalled by Qualgen Due to CGMP...

The Issue: CGMP deviations- Lack of Quality Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 19, 2017· Qualgen

Recalled Item: Estradiol 15 mg pellet 99.5% Estradiol USP Recalled by Qualgen Due to CGMP...

The Issue: CGMP deviations- Lack of Quality Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 18, 2017· Key Pharmacy and Compounding Center

Recalled Item: TESTOST AQ MDV 50MG/ML INJ Recalled by Key Pharmacy and Compounding Center...

The Issue: Lack of Assurance of Sterility: The firm is recalling sterile compounded...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 18, 2017· Sun Pharmaceutical Industries, Inc.

Recalled Item: Children's Cetirizine Hydrochloride Chewable Tablets Recalled by Sun...

The Issue: Failed Tablet/Capsule Specifications: out of specification results for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 18, 2017· Key Pharmacy and Compounding Center

Recalled Item: VIT C/GSH 1.25%-1.25% OPHTH Recalled by Key Pharmacy and Compounding Center...

The Issue: Lack of Assurance of Sterility: The firm is recalling sterile compounded...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund